These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

421 related articles for article (PubMed ID: 25511119)

  • 1. Off-label prescribing in pediatric outpatients.
    Palmaro A; Bissuel R; Renaud N; Durrieu G; Escourrou B; Oustric S; Montastruc JL; Lapeyre-Mestre M
    Pediatrics; 2015 Jan; 135(1):49-58. PubMed ID: 25511119
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Off-label use of psychotropic medications in pediatric wards: a prospective study].
    Winterfeld U; Le Heuzey MF; Acquaviva E; Mouren MC; Brion F; Bourdon O
    Arch Pediatr; 2009 Sep; 16(9):1252-60. PubMed ID: 19640689
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adverse drug reactions and off-label prescribing for paediatric outpatients: a one-year survey of spontaneous reports in Sweden.
    Ufer M; Kimland E; Bergman U
    Pharmacoepidemiol Drug Saf; 2004 Mar; 13(3):147-52. PubMed ID: 15072113
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prescribing for off-label use and unauthorized medicines in three paediatric wards in Finland, the status before and after the European Union Paediatric Regulation.
    Lindell-Osuagwu L; Hakkarainen M; Sepponen K; Vainio K; Naaranlahti T; Kokki H
    J Clin Pharm Ther; 2014 Apr; 39(2):144-53. PubMed ID: 24329556
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Drug utilization and off-label drug use in Spanish pediatric gastroenterology outpatients.
    Ruíz-Antorán B; Piñeiro R; Avendaño C; Román E; Cilleruelo ML; Gutiérrez-Junquera C; Centeno G; Cilleruelo MJ
    J Pediatr Gastroenterol Nutr; 2013 Feb; 56(2):173-7. PubMed ID: 23328455
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Is off-label use a risk factor for adverse drug reactions in pediatric patients? A prospective study in an Indian tertiary care hospital.
    Saiyed MM; Lalwani T; Rana D
    Int J Risk Saf Med; 2015; 27(1):45-53. PubMed ID: 25766066
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The impact of unlicensed and off-label drug use on adverse drug reactions in paediatric patients.
    Neubert A; Dormann H; Weiss J; Egger T; Criegee-Rieck M; Rascher W; Brune K; Hinz B
    Drug Saf; 2004; 27(13):1059-67. PubMed ID: 15471510
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Off-label and unlicensed utilisation of medicines in a French paediatric hospital.
    Joret-Descout P; Prot-Labarthe S; Brion F; Bataille J; Hartmann JF; Bourdon O
    Int J Clin Pharm; 2015 Dec; 37(6):1222-7. PubMed ID: 26394784
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prescribing of medicines in the Danish paediatric population outwith the licensed age group: characteristics of adverse drug reactions.
    Aagaard L; Hansen EH
    Br J Clin Pharmacol; 2011 May; 71(5):751-7. PubMed ID: 21241353
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pediatric Off-Label and Unlicensed Drug Use and Its Implications.
    Gore R; Chugh PK; Tripathi CD; Lhamo Y; Gautam S
    Curr Clin Pharmacol; 2017; 12(1):18-25. PubMed ID: 28322168
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Off-label prescribing for allergic diseases in pre-school children.
    Morais-Almeida M; Cabral AJ
    Allergol Immunopathol (Madr); 2014; 42(4):342-7. PubMed ID: 23769737
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Changes in anticonvulsant prescribing for Australian children: implications for Quality Use of Medicines.
    Cohen SA; Lawson JA; Graudins LV; Pearson SA; Gazarian M
    J Paediatr Child Health; 2012 Jun; 48(6):490-5. PubMed ID: 22050665
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Off-label drug prescriptions among outpatient children and adolescents in Germany--a database analysis].
    Sonntag D; Trebst D; Kiess W; Kapellen T; Bertsche T; Kostev K
    Dtsch Med Wochenschr; 2013 Oct; 138(44):2239-45. PubMed ID: 24150699
    [TBL] [Abstract][Full Text] [Related]  

  • 14. ["Off-label" prescribing of drugs in the ambulatory care of children and adolescents].
    Bücheler R; Meisner C; Kalchthaler B; Mohr H; Schröder H; Mörike K; Schwoerer P; Schwab M; Gleiter CH
    Dtsch Med Wochenschr; 2002 Nov; 127(48):2551-7. PubMed ID: 12457324
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Off-label use of medicines in paediatric inpatients at an Australian teaching hospital.
    Ballard CD; Peterson GM; Thompson AJ; Beggs SA
    J Paediatr Child Health; 2013 Jan; 49(1):38-42. PubMed ID: 23279160
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Off-label psychotropic prescribing for young persons in medium security.
    Haw C; Stubbs J
    J Psychopharmacol; 2010 Oct; 24(10):1491-8. PubMed ID: 19423609
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Off-label prescribing patterns of antidepressants in children and adolescents.
    Lee E; Teschemaker AR; Johann-Liang R; Bazemore G; Yoon M; Shim KS; Daniel M; Pittman J; Wutoh AK
    Pharmacoepidemiol Drug Saf; 2012 Feb; 21(2):137-44. PubMed ID: 21538674
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Drug, patient, and physician characteristics associated with off-label prescribing in primary care.
    Eguale T; Buckeridge DL; Winslade NE; Benedetti A; Hanley JA; Tamblyn R
    Arch Intern Med; 2012 May; 172(10):781-8. PubMed ID: 22507695
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical setting influences off-label and unlicensed prescribing in a paediatric teaching hospital.
    Czarniak P; Bint L; Favié L; Parsons R; Hughes J; Sunderland B
    PLoS One; 2015; 10(3):e0120630. PubMed ID: 25756896
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Off-label prescribing to children in the United States outpatient setting.
    Bazzano AT; Mangione-Smith R; Schonlau M; Suttorp MJ; Brook RH
    Acad Pediatr; 2009; 9(2):81-8. PubMed ID: 19329098
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.